TOP TIERMARKET NEWSWIRE
News & sentiment

ANAPTYSBIO INC (ANAB) — News & AI sentiment

ANAPTYSBIO INC (ANAB) news roundup. 5 stories aggregated over the last 30 days. Average 30-day sentiment is 50/100. No insider transactions filed in the last 90 days. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.

Public view, delayed 4h. For real-time news, alerts, AI sentiment and the long/short AI Top Trades board:Open in the live terminal →
24h stories
0
7d stories
0
30d stories
5
avg sentiment 50/100
Insider net (90d)
$0
0 buys · 0 sells
Congress (90d)
0
0 buys · 0 sells

ANAB news in the last 24 hours, 7 days, 30 days and 90 days

How much ANAB coverage the wire captured in each window, with the average AI sentiment across those stories. Counts are of stories that have cleared the 4-hour public delay.

Time windowANAB storiesAvg AI sentimentRead
Last 24 hours0—no coverage
Last 7 days0—no coverage
Last 30 days550/100ANAB headlines →
Last 90 days1353.5/100ANAB headlines →

Latest stories on ANAB

Sep 9
Sep 1
AnaptysBio stock rating maintained at Outperform by Wolfe Research
Investing.com Analyst Ratings61 · neutralanalyst
Aug 31
TD Cowen lowers Anaptysbio stock price target to $70 on FDA review
Investing.com Analyst Ratings34 · bearishanalyst
Aug 25
Aug 25
Aug 17
Aug 17
Aug 16
ANAPTYSBIO, INC (ANAB) files 8-K
SEC 8-K50 · neutralgeneral
Aug 11
Jul 30
ANAPTYSBIO, INC (ANAB) files 8-K
SEC 8-K50 · neutralgeneral
Jul 30
AnaptysBio: The Royalty Waterfall Is About To Reverse
Seeking Alpha63 · neutralproduct/pr
Jul 29
Jul 14
Jun 22
ANAPTYSBIO, INC (ANAB) files 8-K
SEC 8-K50 · neutralgeneral
Jun 22
May 21
May 10
Open ANAB in the live Top Tier Newswire terminal for real-time stories, sentiment, insider + congress alerts, and the AI Top Trades long/short board.Start a 1-day free trial →